Early-pregnancy insulin resistance is independently associated with approximately twofold higher odds of gestational diabetes mellitus in women with PCOS.
Pregnancy already presents unique metabolic challenges for women with polycystic ovary syndrome (PCOS), but could insulin resistance (IR) make them more vulnerable to gestational diabetes? New research suggests that women with PCOS who have IR early in pregnancy may face substantially higher odds of developing gestational diabetes mellitus (GDM), even after accounting for body mass index (BMI) and other potential confounders.
This retrospective cohort study, led by Zhifen Hua et al., encompassed 168 pregnant women with PCOS. Based on the homeostasis model assessment of insulin resistance (HOMA-IR), subjects were classified into two groups: 52 women with IR (HOMA-IR ≥2.77) and 116 without IR. The authors used multivariable binary logistic regression to examine the link between IR and GDM, adjusting for age, BMI, family history of diabetes, and conception mode.
Key findings
Hence, assessing IR early in pregnancy may help identify PCOS sufferers who are more likely to develop GDM. Early metabolic screening and appropriate risk-based management could support closer monitoring during pregnancy. Nevertheless, the retrospective observational design does not establish causality. Prospective studies are needed to validate the connection and determine whether targeted metabolic management can minimize GDM incidence in PCOS sufferers.
Journal of International Medical Research
Effects of insulin resistance on pregnancy outcomes and complications in women with polycystic ovary syndrome
Zhifen Hua et al.
Comments (0)